CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,169,000 | -35.9% | 74,357 | -32.9% | 0.16% | -31.5% |
| Q1 2018 | $1,824,000 | +13.3% | 110,861 | +24.4% | 0.24% | +10.2% |
| Q4 2017 | $1,610,000 | -30.2% | 89,121 | -25.5% | 0.22% | -33.9% |
| Q3 2017 | $2,308,000 | +75.8% | 119,602 | +7.5% | 0.33% | +70.3% |
| Q2 2017 | $1,313,000 | -13.7% | 111,231 | -19.9% | 0.19% | -10.3% |
| Q1 2017 | $1,521,000 | +95.8% | 138,800 | +29.7% | 0.21% | +100.0% |
| Q4 2016 | $777,000 | – | 107,040 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,951,077 | $178,226,000 | 9.95% |
| Parallel Advisors, LLC | 3,769,455 | $96,649,000 | 4.45% |
| Novo Holdings A/S | 3,327,768 | $85,324,000 | 4.07% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $911,000 | 2.72% |
| Quantedge Capital Pte Ltd | 243,712 | $6,249,000 | 1.93% |
| S&T BANK/PA | 349,456 | $8,960,000 | 1.73% |
| Birchview Capital, LP | 50,000 | $1,282,000 | 0.90% |
| Bridge City Capital, LLC | 61,254 | $1,571,000 | 0.86% |
| FAS Wealth Partners, Inc. | 299,576 | $7,681,000 | 0.85% |
| AJ WEALTH STRATEGIES, LLC | 509,934 | $13,075,000 | 0.76% |